{"disease":{"id":"hypoglycemia-due-to-diabetes-mellitus","name":"Hypoglycemia due to diabetes mellitus","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"dasiglucagon","indication_name":"Hypoglycemia due to diabetes mellitus","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zegalogue","generic_name":"DASIGLUCAGON","company_name":"Zealand Pharma","drug_phase":"marketed","molecular_target":"Glucagon receptor","drug_class":"Antihypoglycemic Agent [EPC]","quality_score":10,"revenue":null,"mechanism":"Zegalogue works by stimulating the release of glucose from stored energy sources in the body."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03655223","title":"Early Check: Expanded Screening in Newborns","phase":"","overall_status":"ENROLLING_BY_INVITATION","enrollment_count":30000,"lead_sponsor_name":"RTI International","has_results":false},{"nct_id":"NCT06297980","title":"Impact of MEnstruation on Glycemic Response and Exercise In Females With Type 1 Diabetes","phase":"NA","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"University of Colorado, Denver","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}